Cargando…

Nebivolol therapy improves QTc and QTcd parameters in heart failure patients

AIM: It has previously been shown that β-blocker therapy reduces QT dynamics in heart failure patients. The aim of this study was to demonstrate this improvement with the third-generation β-blocker, nebivolol. METHODS: A total of 72 heart failure patients with systolic dysfunction were included in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Aksoy, SM, Cay, S, Sen, N, Cagirci, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721958/
https://www.ncbi.nlm.nih.gov/pubmed/22614660
http://dx.doi.org/10.5830/CVJA-2011-046